Sana Biotechnology, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Sana Biotechnology, Inc. (SANA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 185.96 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-10
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 185.96M shares, a 56.09% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 184.19M shares, a 1103.13% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 181.83M shares, a 1229.14% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 119.13M shares, a 1001.03% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 166.43M shares, a 1178.88% increase from fiscal 2020.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 13.01M shares, a 165.43% increase from fiscal 2019.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 4.90M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 185.96M shares 10-Q · filed 2022-05-10 | 185.07M shares derived: average of 2 quarters · filed 2022-05-10 | 183.99M shares derived: average of 3 quarters · filed 2022-05-10 | |
| 2021-12-31 | 184.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | 183.01M shares derived: average of 2 quarters · filed 2022-03-16 | 166.43M shares 10-K · filed 2022-03-16 | |
| 2021-09-30 | 181.83M shares 10-Q · filed 2021-11-08 | 160.51M shares 10-Q · filed 2021-11-08 | ||
| 2021-03-31 | 119.13M shares 10-Q · filed 2022-05-10 | 67.22M shares derived: average of 2 quarters · filed 2022-05-10 | 49.37M shares derived: average of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | 15.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | 14.49M shares derived: average of 2 quarters · filed 2022-03-16 | 13.01M shares 10-K · filed 2022-03-16 | |
| 2020-09-30 | 13.68M shares 10-Q · filed 2021-11-08 | 12.25M shares 10-Q · filed 2021-11-08 | ||
| 2020-03-31 | 10.82M shares 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | 4.90M shares 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |